Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

36.30
Delayed Data
As of Aug 26
 +0.26 / +0.72%
Today’s Change
25.98
Today|||52-Week Range
36.76
+12.59%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close36.04
Today’s open36.07
Day’s range35.91 - 36.44
Volume185,589
Average volume (3 months)437,110
Market cap$1.9B
Dividend yield--
Data as of 4:02pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-11.96%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)+0.02%
P/E ratioNM
Price/Sales1.89
Price/Book2.56

Competitors

 Today’s
change
Today’s
% change
ICUIICU Medical Inc+1.13+0.91%
HYHHalyard Health Inc+0.67+1.87%
GMEDGlobus Medical Inc+0.14+0.62%
PENPenumbra Inc+0.89+1.26%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)$0.35
Annual revenue (last year)$910.5M
Annual profit (last year)-$55.6M
Net profit margin-6.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President &
Chief Executive Officer
Christopher Simon
Chief Financial Officer
William P. Burke
Corporate headquarters
Braintree, Massachusetts

Forecasts

Partner Offers

Search for Jobs